drugset / Trial / NCT02740959

Effects of PG2 on Fatigue-Related Symptom Clusters

NCT02740959 ↗

Completed 6 enrolled Taipei Medical University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is for an "add-on" study to the "main" study (Protocol No.: PH-CP012). The information of patients from main study will be collected by questionnaire survey and actigraphy measurement to evaluate the relationship between fatigue, depression and sleep disorder and the efficacy of PG2 after treatment.The association between symptom cluster and circadian rhythm will be also further explored.

Timeline

Start
2016-03
Primary completion
2017-05-08
Completion
2017-05-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Astragalus Polysaccharides Unknown 250 mg Intravenous
Subject Astragalus Polysaccharides Unknown 500 mg Intravenous